Author:
Zielen Stefan,Duecker Ruth Pia,Woelke Sandra,Donath Helena,Bakhtiar Sharhzad,Buecker Aileen,Kreyenberg Hermann,Huenecke Sabine,Bader Peter,Mahlaoui Nizar,Ehl Stephan,El-Helou Sabine M.,Pietrucha Barbara,Plebani Alessandro,van der Flier Michiel,van Aerde Koen,Kilic Sara S.,Reda Shereen M.,Kostyuchenko Larysa,McDermott Elizabeth,Galal Nermeen,Pignata Claudio,Pérez Juan Luis Santos,Laws Hans-Juergen,Niehues Tim,Kutukculer Necil,Seidel Markus G.,Marques Laura,Ciznar Peter,Edgar John David M.,Soler-Palacín Pere,von Bernuth Horst,Krueger Renate,Meyts Isabelle,Baumann Ulrich,Kanariou Maria,Grimbacher Bodo,Hauck Fabian,Graf Dagmar,Granado Luis Ignacio Gonzalez,Prader Seraina,Reisli Ismail,Slatter Mary,Rodríguez-Gallego Carlos,Arkwright Peter D.,Bethune Claire,Deripapa Elena,Sharapova Svetlana O.,Lehmberg Kai,Davies E. Graham,Schuetz Catharina,Kindle Gerhard,Schubert Ralf
Abstract
AbstractPatients with ataxia-telangiectasia (A-T) suffer from progressive cerebellar ataxia, immunodeficiency, respiratory failure, and cancer susceptibility. From a clinical point of view, A-T patients with IgA deficiency show more symptoms and may have a poorer prognosis. In this study, we analyzed mortality and immunity data of 659 A-T patients with regard to IgA deficiency collected from the European Society for Immunodeficiencies (ESID) registry and from 66 patients with classical A-T who attended at the Frankfurt Goethe-University between 2012 and 2018. We studied peripheral B- and T-cell subsets and T-cell repertoire of the Frankfurt cohort and survival rates of all A-T patients in the ESID registry. Patients with A-T have significant alterations in their lymphocyte phenotypes. All subsets (CD3, CD4, CD8, CD19, CD4/CD45RA, and CD8/CD45RA) were significantly diminished compared to standard values. Patients with IgA deficiency (n = 35) had significantly lower lymphocyte counts compared to A-T patients without IgA deficiency (n = 31) due to a further decrease of naïve CD4 T-cells, central memory CD4 cells, and regulatory T-cells. Although both patient groups showed affected TCR-ß repertoires compared to controls, no differences could be detected between patients with and without IgA deficiency. Overall survival of patients with IgA deficiency was significantly diminished. For the first time, our data show that patients with IgA deficiency have significantly lower lymphocyte counts and subsets, which are accompanied with reduced survival, compared to A-T patients without IgA deficiency. IgA, a simple surrogate marker, is indicating the poorest prognosis for classical A-T patients. Both non-interventional clinical trials were registered at clinicaltrials.gov 2012 (Susceptibility to infections in ataxia-telangiectasia; NCT02345135) and 2017 (Susceptibility to Infections, tumor risk and liver disease in patients with ataxia-telangiectasia; NCT03357978)
Funder
Johann Wolfgang Goethe-Universität, Frankfurt am Main
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy